Targeting NKG2D ligands in glioblastoma with a bispecific T-cell engager is augmented with conventional therapy and enhances oncolytic virotherapy of glioma stem-like cells by Baugh, R, Khalique, H, Page, E, Lei-Rossmann, J, Wan, PK, Johanssen, T, Ebner, D, Ansorge, O, Seymour, LW